Gugel, I.; Kluwe, L.; Zipfel, J.; Teuber, C.; Tatagiba, M.; Mautner, V.-F.; Schuhmann, M.U.; Grimm, F.
Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients. Cancers 2019, 11, 1862.
https://doi.org/10.3390/cancers11121862
AMA Style
Gugel I, Kluwe L, Zipfel J, Teuber C, Tatagiba M, Mautner V-F, Schuhmann MU, Grimm F.
Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients. Cancers. 2019; 11(12):1862.
https://doi.org/10.3390/cancers11121862
Chicago/Turabian Style
Gugel, Isabel, Lan Kluwe, Julian Zipfel, Christian Teuber, Marcos Tatagiba, Victor-Felix Mautner, Martin Ulrich Schuhmann, and Florian Grimm.
2019. "Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients" Cancers 11, no. 12: 1862.
https://doi.org/10.3390/cancers11121862
APA Style
Gugel, I., Kluwe, L., Zipfel, J., Teuber, C., Tatagiba, M., Mautner, V.-F., Schuhmann, M. U., & Grimm, F.
(2019). Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients. Cancers, 11(12), 1862.
https://doi.org/10.3390/cancers11121862